Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2009

Year

Erik Škof, Martina Reberšek, Zvezdana Hlebanja, Janja Ocvirk

BMC Cancer

Abstract

References